Saghir Ali

Also affiliated with The University of Texas Medical Branch at Galveston

Materials ScienceChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022)”.

Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022)

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115476

N/A

0DataRank · unranked

112 citations

Jia Zhou, Saghir Ali

Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023

Current Topics in Medicinal Chemistry(2024)10.2174/0115680266300245240223070242

N/A

0DataRank · unranked

28 citations

Andrew A. Bolinger, Jia Zhou, Saghir Ali

Orphan GPR52 as an emerging neurotherapeutic target

Drug Discovery Today(2024)10.1016/j.drudis.2024.103922

N/A

0DataRank · unranked

25 citations

Pingyuan Wang, Ryan E. Murphy, John Allen, Jia Zhou, Saghir Ali

Highlights on U.S. FDA-approved halogen-containing drugs in 2024

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.117380

N/A

0DataRank · unranked

41 citations

Xiaochen Tian, Salvatore A Meccia, Jia Zhou, Saghir Ali

Old Dog, New Tricks: Ibogaine and Its Analogs as Potential Neurotherapeutics

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c02510

N/A

0DataRank · unranked

2 citations

Xiaochen Tian, Kathryn A. Cunningham, Jia Zhou, Saghir Ali